AUXILIUM PHARAMCEUTICALS INC (AUXL)

Sector:
HEALTH CARE
Industry:
HEALTH CARE
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
N/A
Employees:
639
640 LEE ROAD, CHESTERBROOK, PA 19087
484 321 5900

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, together with its subsidiaries, develops and markets pharmaceutical products for urology and sexual health worldwide.

Data derived from most recent annual or quarterly report
Market Cap 1.946 Billion Shares Outstanding53.37 Million Avg 30-day Volume 1.441 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-2.5
Price to Revenue3.6963 Debt to Equity3.6926 EBITDA-4.778 Million
Price to Book Value9.2944 Operating Margin-27.3314 Enterprise Value2.024 Billion
Current Ratio1.26 EPS Growth-2.536 Quick Ratio0.883
1 Yr BETA 1.0215 52-week High/Low 0.0 / Profit Margin-36.624
Operating Cash Flow Growth-235.0353 Altman Z-Score0.4412 Free Cash Flow to Firm -49.124 Million
View SEC Filings from AUXL instead.

View recent insider trading info

AUXILIUM PHARAMCEUTICALS INC YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding AUXL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AUXL

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD PARTNERS, LP

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
 No longer subject to file 2015-01-29 0

CLASSON ROLF A

  • Director
 0 2015-01-29 0

FETZER OLIVER

  • Director
 0 2015-01-29 0

FRIEDMAN PAUL A

  • Director
 0 2015-01-29 0

MCKEE WILLIAM

  • Director
 0 2015-01-29 0

ADAMS ADRIAN CEO AND PRESIDENT

  • Officer
  • Director
 0 2015-01-29 0

KOVEN ANDREW I EVP, CAO, GC AND SECRETARY

  • Officer
 0 2015-01-29 0

BRANDT PETER C.

  • Director
 0 2015-01-29 0

GLICKMAN MARK A EVP - SALES AND MARKETING

  • Officer
 0 2015-01-29 0

LURKER NANCY

  • Director
 0 2015-01-29 0

WILLS ALAN EVP, CORPORATE DEVELOPMENT

  • Officer
 0 2015-01-29 0

TURSI JAMES PATRICK CHIEF MEDICAL OFFICER

  • Officer
 0 2015-01-29 0

ARMSTRONG JENNIFER LOU SENIOR VICE PRESIDENT, HR

  • Officer
 0 2015-01-29 0

JOBES ELIZABETH VARKI CHIEF COMPLIANCE OFFICER

  • Officer
 0 2015-01-29 0

SAIK ANDREW CFO

  • Officer
 0 2015-01-29 0

FICKENSCHER JAMES E CHIEF FINANCIAL OFFICER

  • Officer
 68,603 2014-06-21 0

DEL TITO BENJAMIN J JR EVP, REG AFFAIRS & PROJECT MGT

  • Officer
 28,533 2014-03-14 0

FUCHS RENATO

  • Director
 1,803 2012-03-30 0

DUDEK RICHARD MICHAEL JR SENIOR VICE PRES., MARKETING

  • Officer
 0 2012-02-14 0

KESSIG EDWARD F SENIOR VICE PRESIDENT, SALES

  • Officer
 0 2011-11-01 0

ANIDO ARMANDO CEO & PRESIDENT

  • Officer
  • Director
 147,136 2011-10-07 0

BAKER BIOTECH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
 844,839 2011-08-01 0

BAKER / TISCH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
 67,322 2011-08-01 0

BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
 5,416,304 2011-08-01 0

14159 CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
 132,889 2011-08-01 0

BAKER BROS. CAPITAL (GP), LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
 0 2011-06-30 0

ALTOMARI ALFRED

  • Director
 0 2011-06-16 0

CHAMBON PHILIPPE O.

  • Director
 7,554 2011-05-23 0

STACEY JENNIFER EVANS EXECUTIVE VP & GENERAL COUNSEL

  • Officer
 16,878 2011-02-28 0

GRAHAM ROGER D JR EVP, SALES & MARKETING

  • Officer
 17,619 2011-02-28 0

ARCURI EDWARD J EVP, TECHNICAL OPERATIONS

  • Officer
 0 2011-02-17 0

LANGER DENNIS

  • Director
 No longer subject to file 2010-06-03 0

BESCHERER EDWIN A JR

  • Director
 0 2010-06-03 0

DELCONTE ANTHONY CHIEF MEDICAL OFFICER

  • Officer
 9,711 2010-03-12 0

MATTILA JYRKI EXECUTIVE VICE PRESIDENT

  • Officer
 0 2009-02-27 0

PURCELL DENNIS J

  • Director
 0 2008-06-12 0

CREDIT SUISSE/

  • 10% Owner
 No longer subject to file 2007-08-22 0

CHURCHILL WINSTON J

  • Director
 15,000 2007-06-13 0

PERSEUS SOROS BIOPHARMACEUTICAL FUND LP

PERSEUS SOROS PARTNERS LLC

PERSEUS BIOTECH FUND PARTNERS LLC

SFM PARTICIPATION LP

SFM AH LLC

PERSEUSPUR LLC

PEARL FRANK H

SOROS FUND MANAGEMENT LLC

SOROS GEORGE

  • 10% Owner
 2,377,403 2006-12-05 0

SCP PRIVATE EQUITY PARTNERS II LP

SCP PRIVATE EQUITY II LLC

  • 10% Owner
 4,436,455 2006-11-21 0

HENWOOD GERALDINE CEO AND INTERIM PRESIDENT

  • Officer
  • Director
 252,496 2006-06-23 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments